129S4(B6N)-Slc1a3tm1.1(cre/ERT2)Wsj/WsjH

Status

Available to order

EMMA IDEM:11807
International strain name129S4(B6N)-Slc1a3tm1.1(cre/ERT2)Wsj/WsjH
Alternative nameSlc1a3-CreERT2
Strain typeTargeted Mutant Strains : Knock-in
Allele/Transgene symbolSlc1a3tm1.1(cre/ERT2)Wsj
Gene/Transgene symbolSlc1a3

Information from provider

ProviderWalker Jackson
Provider affiliationClinical and Experimental Medicine, Linköping University
Genetic informationSequence encoding the Cre-ERT2 fusion protein was inserted in place of the stop codon of the sequence encoding Slc1a3. A 2A peptide separates the two proteins during translation.
Phenotypic informationHomozygous:
This line expresses Cre-ERT2 from the Slc1a3 (or GLAST) locus, leaving the native protein coding sequence intact. The mice appear normal as homozygotes. The oldest age observed is 6 months. The line is still new so not fully characterized. Homozygotes are easily distinguished from heterozygotes by the standard PCR assay.

Heterozygous:
Heterozygotes appear no different from homozygotes or wild-type mice
Breeding historyThe allele was targeted into J1 129S4 ES cells. Chimeras were bred to mice expressing Flp recombinase (from the ROSA26 locus) to remove the selectable marker (neo) that was inserted approximately 200 base pairs downstream of the stop codon. The Flp mice were obtained from Jax on a 129S4 background and were bred in house to carry wild-type Disc1 and the non-agouti gene from C57BL/6N mice. The final genetic background of the Flp mice is >99% 129S4, verified by SNP analysis. The F1 and F2 generations were bred to 129S4 to reintroduce natural alleles of Disc1, agouti, and ROSA26 from 129S4. F3 and F4 generations were intercrossed to generate and expand a homozygous line. They currently exist at the F5 generation.
References
  • Slc1a3-2A-CreERT2 mice reveal unique features of Bergmann glia and augment a growing collection of Cre drivers and effectors in the 129S4 genetic background.;Kaczmarczyk Lech, Reichenbach Nicole, Blank Nelli, Jonson Maria, Dittrich Lars, Petzold Gabor C, Jackson Walker S, ;2021;Scientific reports;11;5412; 33686166
Homozygous fertileyes
Homozygous viableyes
Homozygous matings requiredno
Immunocompromisedno

Information from EMMA

Archiving centreMary Lyon Centre at MRC Harwell, Oxford, United Kingdom

Disease and phenotype information

Orphanet associated rare diseases, based on orthologous gene matching

IMPC phenotypes (gene matching)
  • increased vertical activity / IMPC
  • abnormal sleep behavior / IMPC
MGI phenotypes (gene matching)
  • abnormal Purkinje cell morphology / MGI
  • retinal degeneration / MGI
  • abnormal optic nerve morphology / MGI
  • abnormal kindling response / MGI
  • abnormal motor coordination/balance / MGI
  • seizures / MGI
  • increased susceptibility to pharmacologically induced seizures / MGI
  • abnormal excitatory postsynaptic currents / MGI
  • increased lactate dehydrogenase level / MGI
  • nervous system phenotype / MGI
  • abnormal nervous system physiology / MGI
  • abnormal retinal inner nuclear layer morphology / MGI
  • cochlear inner hair cell degeneration / MGI
  • abnormal synaptic glutamate release / MGI
  • increased susceptibility to noise-induced hearing loss / MGI
  • increased susceptibility to ototoxicity-induced hearing loss / MGI
  • abnormal retinal ganglion layer morphology / MGI
  • behavior/neurological phenotype / MGI
  • vision/eye phenotype / MGI
  • optic nerve cupping / MGI
  • optic nerve degeneration / MGI
  • decreased retinal ganglion cell number / MGI
  • increased cellular sensitivity to hydrogen peroxide / MGI
  • abnormal auditory brainstem response waveform shape / MGI
  • increased or absent threshold for auditory brainstem response / MGI
  • abnormal electroretinogram waveform feature / MGI

Literature references

  • Slc1a3-2A-CreERT2 mice reveal unique features of Bergmann glia and augment a growing collection of Cre drivers and effectors in the 129S4 genetic background.;Kaczmarczyk Lech, Reichenbach Nicole, Blank Nelli, Jonson Maria, Dittrich Lars, Petzold Gabor C, Jackson Walker S, ;2021;Scientific reports;11;5412; 33686166

Information on how we integrate external resources can be found here

Order

Availabilities

Requesting frozen sperm or embryos is generally advisable wherever possible, in order to minimise the shipment of live mice.

  • Frozen sperm. Delivered in 4 weeks (after paperwork in place). €1740*
  • Rederivation of mice from frozen stock, delivery time available upon request . €3880*
  • Tissue - Types of tissue, service fee and delivery time available upon request

Due to the dynamic nature of our processes strain availability may change at short notice. The local repository manager will advise you in these circumstances.

* In addition users have to cover all the shipping costs (including the cost for returning dry-shippers, where applicable).

More details on pricing and delivery times

Practical information

Example health report
(Current health report will be provided later)

Material Transfer Agreement (MTA)
MTA will be issued after an order has been submitted.

EMMA conditions
Legally binding conditions for the transfer

Other EMMA strains

Not found what you were looking for? Search here for other strains available from EMMA.


Search
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).